List of Octapharma patents

Patents where

Current Assignee

Name

Octapharma

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7553938 Method of providing a purified, virus safe antibody preparation	Patent 7553938 was granted and assigned to Octapharma on June, 2009 by the United States Patent and Trademark Office.		Octapharma	United States Patent and Trademark Office	7553938	June 30, 2009
‌ US Patent 11383001 Plasma-based films and methods for making and using the same		Octapharma	Octapharma	United States Patent and Trademark Office	11383001	July 12, 2022
‌ US Patent 11383002 Plasma-based films and methods for making and using the same	Patent 11383002 was granted and assigned to Octapharma on July, 2022 by the United States Patent and Trademark Office.	Octapharma	Octapharma	United States Patent and Trademark Office	11383002	July 12, 2022
‌ US Patent 7166709 Haemostatically active preparation containing vWF and method for the production thereof	Patent 7166709 was granted and assigned to Octapharma on January, 2007 by the United States Patent and Trademark Office.		Octapharma	United States Patent and Trademark Office	7166709	January 23, 2007
‌ US Patent 9453045 Process for the purification of a growth factor protein	Patent 9453045 was granted and assigned to Octapharma on September, 2016 by the United States Patent and Trademark Office.		Octapharma	United States Patent and Trademark Office	9453045	September 27, 2016
‌ US Patent 11401300 Process for production of fibrinogen and fibrinogen produced thereby	Patent 11401300 was granted and assigned to Octapharma on August, 2022 by the United States Patent and Trademark Office.	Octapharma	Octapharma	United States Patent and Trademark Office	11401300	August 2, 2022
‌ US Patent 8518452 Method for stabilizing blood plasma components in a lyophilizate using carbon dioxide and phosphoric acid	Patent 8518452 was granted and assigned to Octapharma on August, 2013 by the United States Patent and Trademark Office.		Octapharma	United States Patent and Trademark Office	8518452	August 27, 2013
‌ US Patent 8329871 Process of purifying coagulation factor VIII	Patent 8329871 was granted and assigned to Octapharma on December, 2012 by the United States Patent and Trademark Office.		Octapharma	United States Patent and Trademark Office	8329871	December 11, 2012
‌ US Patent 9296799 Process for isolation and purification of a target protein free of prion protein (PrP	Patent 9296799 was granted and assigned to Octapharma on March, 2016 by the United States Patent and Trademark Office.		Octapharma	United States Patent and Trademark Office	9296799	March 29, 2016
‌ US Patent 9512457 Serum-free stable transfection and production of recombinant human proteins in human cell lines	Patent 9512457 was granted and assigned to Octapharma on December, 2016 by the United States Patent and Trademark Office.		Octapharma	United States Patent and Trademark Office	9512457	December 6, 2016
‌ US Patent 8962813 Purification and use of a factor for supporting wound healing	Patent 8962813 was granted and assigned to Octapharma on February, 2015 by the United States Patent and Trademark Office.		Octapharma	United States Patent and Trademark Office	8962813	February 24, 2015
‌ US Patent 9796986 Serum-free stable transfection and production of recombinant human proteins in human cell lines	Patent 9796986 was granted and assigned to Octapharma on October, 2017 by the United States Patent and Trademark Office.	Octapharma	Octapharma	United States Patent and Trademark Office	9796986	October 24, 2017
‌ US Patent 8436142 Processing of recombinant human G-CSF precursor	Patent 8436142 was granted and assigned to Octapharma on May, 2013 by the United States Patent and Trademark Office.		Octapharma	United States Patent and Trademark Office	8436142	May 7, 2013
‌ US Patent 9901597 Method for inactivation/removal of coagulation factors by precipitation	Patent 9901597 was granted and assigned to Octapharma on February, 2018 by the United States Patent and Trademark Office.		Octapharma	United States Patent and Trademark Office	9901597	February 27, 2018
‌ US Patent 7985846 Hemostatically active vWF-containing preparation and process for the preparation thereof	Patent 7985846 was granted and assigned to Octapharma on July, 2011 by the United States Patent and Trademark Office.		Octapharma	United States Patent and Trademark Office	7985846	July 26, 2011
‌ US Patent 10214575 Process for the purification of a growth factor protein	Patent 10214575 was granted and assigned to Octapharma on February, 2019 by the United States Patent and Trademark Office.	Octapharma	Octapharma	United States Patent and Trademark Office	10214575	February 26, 2019
‌ US Patent 8769841 Lyophilisation targeting defined residual moisture by limited desorption energy levels	Patent 8769841 was granted and assigned to Octapharma on July, 2014 by the United States Patent and Trademark Office.	Octapharma	Octapharma	United States Patent and Trademark Office	8769841	July 8, 2014
‌ US Patent 9371355 Process for production of fibrinogen	Patent 9371355 was granted and assigned to Octapharma on June, 2016 by the United States Patent and Trademark Office.		Octapharma	United States Patent and Trademark Office	9371355	June 21, 2016
‌ US Patent 9943600 Stabilizing agent for pharmaceutical proteins	Patent 9943600 was granted and assigned to Octapharma on April, 2018 by the United States Patent and Trademark Office.	Octapharma	Octapharma	United States Patent and Trademark Office	9943600	April 17, 2018
‌ US Patent 7700732 Prekallikrein depleted plasma derived albumin fraction	Patent 7700732 was granted and assigned to Octapharma on April, 2010 by the United States Patent and Trademark Office.		Octapharma	United States Patent and Trademark Office	7700732	April 20, 2010
‌ US Patent 11013789 Polypeptides modulating SIGLEC dependent immune responses	Patent 11013789 was granted and assigned to Octapharma on May, 2021 by the United States Patent and Trademark Office.	Octapharma	Octapharma	United States Patent and Trademark Office	11013789	May 25, 2021
‌ US Patent 9388402 Method for improved isolation of recombinantly produced proteins	Patent 9388402 was granted and assigned to Octapharma on July, 2016 by the United States Patent and Trademark Office.		Octapharma	United States Patent and Trademark Office	9388402	July 12, 2016
‌ US Patent 9938318 Process for production of fibrinogen	Patent 9938318 was granted and assigned to Octapharma on April, 2018 by the United States Patent and Trademark Office.	Octapharma	Octapharma	United States Patent and Trademark Office	9938318	April 10, 2018
‌ US Patent 10640548 Method for inactivation/removal of coagulation factors by precipitation	Patent 10640548 was granted and assigned to Octapharma on May, 2020 by the United States Patent and Trademark Office.	Octapharma	Octapharma	United States Patent and Trademark Office	10640548	May 5, 2020
‌ US Patent 8809510 Method for purification of complement factor H	Patent 8809510 was granted and assigned to Octapharma on August, 2014 by the United States Patent and Trademark Office.		Octapharma	United States Patent and Trademark Office	8809510	August 19, 2014

Results per page:

37 results

0 selected

37 results

0 selected